Search results
Results from the WOW.Com Content Network
They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people ...
According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy, and ...
According to recent research, semaglutide drugs, such as Ozempic and Wegovy, are linked to a lower risk of cognitive problems, as well as reduced cravings for nicotine.
The Dementia Training Australia funding an interactive online education package for deprescribing in dementia centered around the MATCH-D. It was a joint collaboration between the University of Western Australia, University of Tasmania, La Trobe University, Monash University, Alfred Health and FireFilms.
Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. [19] [20] [21] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. [22] [23] It can be administered by subcutaneous injection or taken orally.
A recent study found that a class of medications called SGLT-2 inhibitors—which does not include Ozempic or similar drugs like Zepbound—significantly lowered the risk of dementia in people ...
The study found Ozempic, or semaglutide, was not tied to a higher risk of any of the neurological or psychiatric conditions studied, such as anxiety or depression, and patients taking Ozempic had lowe
The success of weight loss drugs like Ozempic heavily relies on the effect that they have in your brain, too, according to doctors. This is how GLP-1s impact your mind. ... is an obesity medicine ...